Arcus Ventures
Status
ACTIVE
Global HQ
New York, United States
Countries of investment
- USA: Maryland
- California
- Texas
- North Carolina
- Massachusetts; Germany: Munich.
Investment stages
- Seed
- Series A
Industries
- Health Tech
- Biotechnology
About
Arcus Ventures (AV) consists of a team of professionals with experience in clinical and academic medicine, drug development, hospital management, healthcare industry consulting, and private equity. AV is dedicated to investing in oncologyfocused companies with innovative biopharmaceuticals and/or new drug delivery platforms in development, device companies with products that have premarketing approval, and service companies with positive revenue.
Arcus Ventures (AV) consists of a team of professionals with experience in clinical and academic medicine, drug development, hospital management, healthcare industry consulting, and private equity. AV is dedicated to investing in oncologyfocused companies with innovative biopharmaceuticals and/or new drug delivery platforms in development, device companies with products that have premarketing approval, and service companies with positive revenue.
Investment Thesis
Arcus Ventures is dedicated to investing in oncologyfocused companies with innovative biopharmaceuticals, new drug delivery platforms in development, device companies with premarketing approval, and service companies with positive revenue.
Arcus Ventures Contacts Information
Team
James B. Dougherty
MD
MBA General Partner
Steven L. Soignet
MD General Partner
Chad C. Hellmann
MBA Chief Financial Officer
Portfolio
MacroGenics
Tracon
T2 Biosystems
Clear Vascular
Inc.
Epic Sciences
Cleave Therapeutics
Palyon Medical
MI Bioresearch
Vascular Pathways
Oncoscope
Exosome Diagnostics
XTuit Pharmaceuticals
Genta